ムコ多糖症（MPS）治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Mucopolysaccharidosis (MPS) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C3880
• 出版社/出版日：GlobalInfoResearch / 2019年8月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール
• 産業分類：Medical Care

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、ムコ多糖症（MPS）治療の世界市場について調べ、まとめました。種類別セグメントは、幹細胞療法、酵素補充療法等、用途別セグメントは、病院、診療所、その他等に区分しました。ムコ多糖症（MPS）治療の世界市場概観、企業動向、企業別ムコ多糖症（MPS）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・ムコ多糖症（MPS）治療の市場概観
・ムコ多糖症（MPS）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・ムコ多糖症（MPS）治療の企業別販売動向、市場シェア、市場集中度、競争動向
・ムコ多糖症（MPS）治療の世界市場規模
・ムコ多糖症（MPS）治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・ムコ多糖症（MPS）治療のアメリカ市場規模推移
・ムコ多糖症（MPS）治療のカナダ市場規模推移
・ムコ多糖症（MPS）治療のメキシコ市場規模推移
・ムコ多糖症（MPS）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・ムコ多糖症（MPS）治療のドイツ市場規模推移
・ムコ多糖症（MPS）治療のイギリス市場規模推移
・ムコ多糖症（MPS）治療のロシア市場規模推移
・ムコ多糖症（MPS）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・ムコ多糖症（MPS）治療の日本市場規模推移
・ムコ多糖症（MPS）治療の中国市場規模推移
・ムコ多糖症（MPS）治療の韓国市場規模推移
・ムコ多糖症（MPS）治療のインド市場規模推移
・ムコ多糖症（MPS）治療の東南アジア市場規模推移
・ムコ多糖症（MPS）治療の南米市場分析（ブラジル、アルゼンチン等）
・ムコ多糖症（MPS）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・ムコ多糖症（MPS）治療の種類別分析/販売量、売上、市場シェア（幹細胞療法、酵素補充療法）
・ムコ多糖症（MPS）治療の用途別分析/市場規模（病院、診療所、その他）
・ムコ多糖症（MPS）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・ムコ多糖症（MPS）治療の販売チャネル・代理店・貿易業者・ディーラー分析

Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and connective tissue. Glycosaminoglycans (formerly called mucopolysaccharides) are also found in the fluids that lubricate joints.

Scope of the Report:
The global Mucopolysaccharidosis (MPS) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mucopolysaccharidosis (MPS) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Mucopolysaccharidosis (MPS) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mucopolysaccharidosis (MPS) Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Sanofi
Shire (Takeda)
BioMarin Pharmaceutical
Esteve
REGENXBIO Inc
Sangamo Therapeutics
Ultragenyx Pharmaceutical
Abeona Therapeutics
ArmaGen
Eloxx Pharmaceuticals
Inventiva

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Stem Cell Therapies
Enzyme Replacement Therapies

Market Segment by Applications, can be divided into
Hospitals
Clinics
Homecare

レポート目次

Table of Contents

1 Mucopolysaccharidosis (MPS) Treatment Market Overview
1.1 Product Overview and Scope of Mucopolysaccharidosis (MPS) Treatment
1.2 Classification of Mucopolysaccharidosis (MPS) Treatment by Types
1.2.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Types in 2018
1.2.3 Stem Cell Therapies
1.2.4 Enzyme Replacement Therapies
1.3 Global Mucopolysaccharidosis (MPS) Treatment Market by Application
1.3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.4 Global Mucopolysaccharidosis (MPS) Treatment Market by Regions
1.4.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Mucopolysaccharidosis (MPS) Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shire (Takeda)
2.2.1 Business Overview
2.2.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioMarin Pharmaceutical
2.3.1 Business Overview
2.3.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Esteve
2.4.1 Business Overview
2.4.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 REGENXBIO Inc
2.5.1 Business Overview
2.5.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sangamo Therapeutics
2.6.1 Business Overview
2.6.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Ultragenyx Pharmaceutical
2.7.1 Business Overview
2.7.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Abeona Therapeutics
2.8.1 Business Overview
2.8.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 ArmaGen
2.9.1 Business Overview
2.9.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Eloxx Pharmaceuticals
2.10.1 Business Overview
2.10.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Inventiva
2.11.1 Business Overview
2.11.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Mucopolysaccharidosis (MPS) Treatment Market Competition, by Players
3.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Mucopolysaccharidosis (MPS) Treatment Players Market Share
3.2.2 Top 10 Mucopolysaccharidosis (MPS) Treatment Players Market Share
3.3 Market Competition Trend
4 Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions
4.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue and Market Share by Regions
4.2 North America Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
5 North America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries
5.1 North America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
5.2 USA Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Mucopolysaccharidosis (MPS) Treatment Revenue by Countries
6.1 Europe Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
6.2 Germany Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
6.4 France Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue by Countries
7.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
7.2 China Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
7.5 India Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
8 South America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries
8.1 South America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
8.2 Brazil Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Mucopolysaccharidosis (MPS) Treatment by Countries
9.1 Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
10 Global Mucopolysaccharidosis (MPS) Treatment Market Segment by Type
10.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Mucopolysaccharidosis (MPS) Treatment Market Forecast by Type (2019-2024)
10.3 Stem Cell Therapies Revenue Growth Rate (2014-2024)
10.4 Enzyme Replacement Therapies Revenue Growth Rate (2014-2024)
11 Global Mucopolysaccharidosis (MPS) Treatment Market Segment by Application
11.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Application (2014-2019)
11.2 Mucopolysaccharidosis (MPS) Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Homecare Revenue Growth (2014-2019)
12 Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast (2019-2024)
12.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast (2019-2024)
12.2 Global Mucopolysaccharidosis (MPS) Treatment Market Forecast by Regions (2019-2024)
12.3 North America Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
12.6 South America Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Mucopolysaccharidosis (MPS) Treatment Picture
Table Product Specifications of Mucopolysaccharidosis (MPS) Treatment
Table Global Mucopolysaccharidosis (MPS) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Types in 2018
Figure Stem Cell Therapies Picture
Figure Enzyme Replacement Therapies Picture
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Application (2014-2024)
Figure Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Homecare Picture
Table Global Market Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shire (Takeda) Basic Information, Manufacturing Base and Competitors
Table Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Esteve Basic Information, Manufacturing Base and Competitors
Table Esteve Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table REGENXBIO Inc Basic Information, Manufacturing Base and Competitors
Table REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Ultragenyx Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Abeona Therapeutics Basic Information, Manufacturing Base and Competitors
Table Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table ArmaGen Basic Information, Manufacturing Base and Competitors
Table ArmaGen Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Eloxx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Inventiva Basic Information, Manufacturing Base and Competitors
Table Inventiva Mucopolysaccharidosis (MPS) Treatment Type and Applications
Table Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Players (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Players in 2017
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Mucopolysaccharidosis (MPS) Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Mucopolysaccharidosis (MPS) Treatment Revenue Market Share in 2018
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Regions in 2018
Figure North America Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure South America Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Table North America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
Table North America Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries in 2018
Figure USA Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries in 2018
Figure Germany Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure UK Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure France Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries in 2018
Figure China Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure India Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Table South America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)
Table South America Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Type (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Type (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Type in 2018
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue Forecast by Type (2019-2024)
Figure Global Mucopolysaccharidosis (MPS) Treatment Market Share Forecast by Type (2019-2024)
Figure Global Stem Cell Therapies Revenue Growth Rate (2014-2019)
Figure Global Enzyme Replacement Therapies Revenue Growth Rate (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue by Application (2014-2019)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Application (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Application (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Share by Application in 2018
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue Forecast by Application (2019-2024)
Figure Global Mucopolysaccharidosis (MPS) Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Homecare Revenue Growth Rate (2014-2019)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Mucopolysaccharidosis (MPS) Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
Figure Europe Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
Figure South America Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C3509 2019年7月 120Pages
本調査レポートは、リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場について調べ、まとめました。種類別セグメントは、酵素補充療法、腎臓移植、幹細胞移植等、用途別セグメントは、等に区分しました。リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場概観、企業動向、企業別リソソーム酸リパーゼ欠乏症（LA...

神経内分泌腫瘍（NET）治療の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Neuroendocrine Tumors (NETs) Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C3995 2019年8月 119Pages
本調査レポートは、神経内分泌腫瘍（NET）治療の世界市場について調べ、まとめました。種類別セグメントは、ソマトスタチンアナログ（SSA）、標的療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経内分泌腫瘍（NET）治療の世界市場概観、企業動向、企業別神経内分泌腫瘍（NET）...

幹細胞脱毛症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Stem Cell Alopecia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5523 2019年7月 105Pages
本調査レポートは、幹細胞脱毛症治療の世界市場について調べ、まとめました。種類別セグメントは、円形脱毛症、全頭脱毛症、全身性脱毛症等、用途別セグメントは、等に区分しました。幹細胞脱毛症治療の世界市場概観、企業動向、企業別幹細胞脱毛症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要...

すくみ足治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Freezing of Gait Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C2406 2019年7月 102Pages
本調査レポートは、すくみ足治療の世界市場について調べ、まとめました。種類別セグメントは、経口ドーパミン作動薬、ウェアラブルおよび歩行補助器具、深部脳刺激、その他等、用途別セグメントは、等に区分しました。すくみ足治療の世界市場概観、企業動向、企業別すくみ足治療シェア、市場規模推移、市場規模予測（201...

くる病治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Rickets Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4958 2019年7月 115Pages
本調査レポートは、くる病治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンDサプリメント、カルシウムサプリメント等、用途別セグメントは、等に区分しました。くる病治療の世界市場概観、企業動向、企業別くる病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析...

ビタミンD欠乏症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Vitamin D Deficiency Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6250 2019年7月 123Pages
本調査レポートは、ビタミンD欠乏症治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンD2、ビタミンD3等、用途別セグメントは、等に区分しました。ビタミンD欠乏症治療の世界市場概観、企業動向、企業別ビタミンD欠乏症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主...

学習障害治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Learning Disability Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C3309 2019年7月 101Pages
本調査レポートは、学習障害治療の世界市場について調べ、まとめました。種類別セグメントは、興奮剤、非興奮剤、その他の薬等、用途別セグメントは、等に区分しました。学習障害治療の世界市場概観、企業動向、企業別学習障害治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨー...

ドナーエッグIVF治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Donor Egg IVF Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1840 2019年7月 100Pages
本調査レポートは、ドナーエッグIVF治療の世界市場について調べ、まとめました。種類別セグメントは、フレッシュドナーエッグIVFサイクル、冷凍ドナーエッグIVFサイクル等、用途別セグメントは、等に区分しました。ドナーエッグIVF治療の世界市場概観、企業動向、企業別ドナーエッグIVF治療シェア、市場規模...

レア血液学的治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Rare Hematology Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4856 2019年7月 121Pages
本調査レポートは、レア血液学的治療の世界市場について調べ、まとめました。種類別セグメントは、血漿由来因子、組換え因子等、用途別セグメントは、等に区分しました。レア血液学的治療の世界市場概観、企業動向、企業別レア血液学的治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北...

アルファサラセミア治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Alpha Thalassemia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C0199 2019年7月 106Pages
本調査レポートは、アルファサラセミア治療の世界市場について調べ、まとめました。種類別セグメントは、葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素等、用途別セグメントは、等に区分しました。アルファサラセミア治療の世界市場概観、企業動向、企業別アルファサラセミア治療シェア、市場規模推移、市場規模...

幹細胞脱毛症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Stem Cell Alopecia Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…
リソソーム酸リパーゼ欠乏症（LAAL）治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Lysosomal Acid Lipase Deficiency (LAAL) Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
ゴーシェ病治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Gaucher Disease Treatment market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast…
世界のT細胞性急性リンパ芽球性白血病の治療市場：市場規模・現状・予測 T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes.In 2018, the global T-cell Acute Lymphoblastic Leukemia Treatment market size was xx million US$ and it is expected to reach xx …
世界の慢性関節リウマチの治療市場：市場規模・現状・予測 Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints.The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. In 2018, the global Rheumatoid Arthritis Treatment marke…